SEO URLwww.firestrike.ai/deals/newcells-biotech-axol-bioscience-acquisition-2026
acquisitionAnnounced · Feb 18, 2026Drug Discovery & PharmaceuticalsSource · MagazinesArticle · Factual
Axol Bioscience acquires Newcells Biotech
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Newcells Biotech
Newcastle upon Tyne, Tyne and Wear
Acquirer
Axol Bioscience
Asset/Business Division Sale
Status
Announced
Axol Bioscience agreed to acquire Newcells Biotech. Reported deal value: Undisclosed. Status: Announced. Sector: Drug Discovery & Pharmaceuticals. Target headquarters context: Newcastle upon Tyne, Tyne and Wear, United Kingdom.
This page summarizes publicly available information about the transaction as of 2026-02-18. Figures and status may change as filings and press coverage update.
Axol Bioscience acquires ophthalmology business from Newcells Biotech
Deal timeline
Announced
Feb 18, 2026 · news-medical.net
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Drug Discovery & Pharmaceuticals. Figures and status may change as sources update.
Sources: news-medical.net · Primary article · FireStrike proprietary index